dr Maša Ždralević
naučni saradnik | Institut za napredne studije Dr Maša Ždralević rođena je 07.08.1985. godine u Nikšiću, gdje je završila osnovnu i srednju školu, kao učenik generacije u osnovnoj i dobitnik diplome « Luča » u srednjoj školi. Osnovne četvorogodišnje akademske studije na Prirodno-matematičkom fakultetu, Odsjeku za Biologiju, Univerziteta Crne Gore u Podgorici završila je u aprilu 2008. godine sa srednjom ocjenom 9,81/10. Dobitnik je nagrade Prirodno-matematičkog fakulteta za najboljeg studenta Odsjeka za...
Nastava
| Jedinica | Program | Tip | Sem. | Predmet | P x GP | V x GV | L x GL |
|---|
Izabrane publikacije
| Godina | Kategorija | Autori | Naslov | Izvor |
|---|---|---|---|---|
| 2023 | SCI, SCIE, SSCI, A&HCI | Ždralević M, Raonić J, Popovic N, Vučković L, Rovčanin Dragović I, Vukčević B, Todorović V, Vukmirović F, Marzano F, Tullo A, Guaragnella N, Giannattasio S, Radunović M | The role of miRNA in colorectal cancer diagnosis: A pilot study | Oncology Letters |
| 2023 | SCI, SCIE, SSCI, A&HCI | Ždralević M and Pouyssegur J | Editorial: Immunometabolism and therapeutic targeting of aggressive cancers | Front Oncol |
| 2023 | SCI, SCIE, SSCI, A&HCI | Popovic N, Ždralević M, Vujosevic S, Radunović M, Adžić Zečević A, Rovčanin Dragović I, Vukčević B, Popovic T, Radulović L, Vuković T, Eraković J, Lazović R, Radunović M | Retinal microvascular complexity as a putative biomarker of biological age: a pilot study | Biogerontology |
| 2023 | SCI, SCIE, SSCI, A&HCI | Lalatović, N., Ždralević, M., Antunović, T., and Pantović, S. | Genetic polymorphisms in ABCB1 are correlated with the increased risk of atorvastatin-induced muscle side effects: a cross-sectional study | Sci Rep |
| 2022 | SCI, SCIE, SSCI, A&HCI | Ždralević M, Giannattasio S. | Mitochondrial Research: Yeast and Human Cells as Models | International Journal of Molecular Sciences |
| 2022 | SCI, SCIE, SSCI, A&HCI | Pouysségur J, Marchiq I, Parks SK, Durivault J, Ždralević M, Vucetic M | Warburg effect controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives | Semin Cancer Biol |
| 2022 | SCI, SCIE, SSCI, A&HCI | Pejakov Lj, Ždralević M, Đurišić I | Propofol doses differ in total intravenous anaesthesia (TIVA) for cancer and no cancer surgery - observational cohort study | Eur Rev Med Pharmacol Sci |
| 2022 | SCI, SCIE, SSCI, A&HCI | Rovčanin Dragović I, Popović N, Ždralević M, Radulović L, Vuković T, Marzano F, Tullo A, Radunović M | Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro | J Alzheimers Dis. |
| 2022 | SCI, SCIE, SSCI, A&HCI | Gotorbe C, Durivault J, Meira W, Cassim S, Ždralević M, Pouysségur J, Vučetić M. | Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells | Antioxidants |
| 2021 | SCI, SCIE, SSCI, A&HCI | Nirvana Sadaghianloo, Julie Contenti, Serge Declemy, Damien Ambrosetti, Masa Zdralevic, Mounia Tannour-Louet, Lucilla Fabbri, Gilles Pagès, Frédéric Bost, Réda Hassen-Khodja, Jacques Pouysségur, Elixène Jean-Baptiste, Alan Dardik, Nathalie M Mazure | Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula | Journal of Physiology |
| 2021 | SCOPUS | Nicoletta Guaragnella, Maša Ždralević, Zdena Palková, Sergio Giannattasio | Analysis of Mitochondrial Retrograde Signaling in Yeast Model Systems | Methods Mol Biol |
| 2021 | SCI, SCIE, SSCI, A&HCI | Melissa Schwab, Katharina Thunborg, Omid Azimzadeh, Christine von Toerne, Caroline Werner, Maxim Shevtsov, Tommaso Di Genio, Masa Zdralevic, Jacques Pouyssegur, Kathrin Renner, Marina Kreutz and Gabriele Multhoff | Targeting Cancer Metabolism Breaks Radioresistance by Impairing the Stress Response | Cancers |
| 2020 | SCI, SCIE, SSCI, A&HCI | Shamir Cassim, Milica Vučetić, Maša Ždralević and Jacques Pouyssegur | Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer | Cancers |
| 2020 | SCI, SCIE, SSCI, A&HCI | Elizabeth Mazzio, Ramesh Badisa, Nzinga Mack, Shamir Cassim, Masa Zdralevic, Jacques Pouyssegur, Karam F A Soliman | Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase | Cancer Genomics Proteomics |
| 2019 | SCOPUS | Pouysségur J, Ždralević M | Reply to Beltinger: Double genetic disruption of lactate dehydrogenases A and B is required to ablate the | J Biol Chem |
| 2018 | SCI, SCIE, SSCI, A&HCI | Ždralević M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, Peter K, Schnell A, Bruss C, Decking SM, Koehl G, Felipe-Abrio B, Durivault J, Bayer P, Evangelista M, O'Brien T, Oefner PJ, Renner K, Pouysségur J, Kreutz M | Double genetic disruption of lactate dehydrogenase A and B is required to ablate the 'Warburg effect' restricting tumor growth to oxidative metabolism | Journal of Biochemistry |
| 2018 | SCOPUS | Ždralević M, Vučetić M, Daher B, Marchiq I, Parks SK, Pouysségur J | Disrupting the 'Warburg effect' re-routes cancer cells to OXPHOS offering a vulnerability point via 'ferroptosis'-induced cell death | Adv Biol Regul |
| 2017 | SCI, SCIE, SSCI, A&HCI | Ždralević M, Marchiq I, de Padua MMC, Parks SK, Pouysségur J | Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs | Frontiers in Oncology |
| 2017 | SCOPUS | de Padua MC, Delodi G, Vučetić M, Durivault J, Vial V, Bayer P, Noleto GR, Mazure NM, Ždralević M, Pouysségur J | Disrupting glucose-6-phosphate isomerase fully suppresses the "Warburg effect" and activates OXPHOS with minimal impact on tumor growth except in hypoxia | Oncotarget |
| 2016 | SCOPUS | Luna Laera, Nicoletta Guaragnella, Maša Ždralević, Domenico Marzulli, Zhengchang Liu, Sergio Giannattasio | The Transcription Factors ADR1 or CAT8 Are Required for RTG Pathway Activation and Evasion From Yeast Acetic Acid-Induced Programmed Cell Death in Raffinose | Microbial Cell |
| 2015 | SCI, SCIE, SSCI, A&HCI SCOPUS | Ždralević M, Longo V, Guaragnella N, Giannattasio S, Timperio AM, Zolla L | Differential proteome-metabolome profiling of YCA1-knock-out and wild type cells reveals novel metabolic pathways and cellular processes dependent on the yeast metacaspase | Molecular BioSystems |
| 2015 | SCOPUS | Ždralević M, Guaragnella N, Giannattasio S | Yeast as a tool to study mitochondrial retrograde pathway en route to cell stress response | Methods in Molecular Biology |
| 2015 | SCI, SCIE, SSCI, A&HCI | Longo V, Ždralević M, Guaragnella N, Giannattasio S, Zolla L, Timperio AM | Proteome and metabolome profiling of wild-type and YCA1-knock-out yeast cells during acetic acid-induced programmed cell death | Journal of Proteomics |
| 2013 | SCI, SCIE, SSCI, A&HCI | Guaragnella N, Ždralević M, Lattanzio P, Marzulli D, Pracheil T, Liu Z, Passarella S, Marra E, Giannattasio S | Yeast growth in raffinose results in resistance to acetic-acid induced programmed cell death mostly due to the activation of the mitochondrial retrograde pathway | Biochimica et Biophysica Acta - Molecular Cell Research |
| 2013 | SCI, SCIE, SSCI, A&HCI | Giannattasio S, Guaragnella N, Zdralević M, Marra E | Molecular mechanisms of Saccharomyces cerevisiae stress adaptation and programmed cell death in response to acetic acid | Frontiers in Microbiology |
| 2012 | SCOPUS | Zdralević M, Guaragnella N, Antonacci L, Marra E, Giannattasio S | Yeast as a tool to study signaling pathways in mitochondrial stress response and cytoprotection | The Scientific World Journal |
| 2012 | SCI, SCIE, SSCI, A&HCI | Guaragnella N, Zdralević M, Antonacci L, Passarella S, Marra E, Giannattasio S | The role of mitochondria in yeast programmed cell death | Frontiers in Oncology |
| 2012 | SCI, SCIE, SSCI, A&HCI | Antonacci L, Guaragnella N, Ždralevic M, Passarella S, Marra E, Giannattasio S | The N-acetylcysteine-insensitive acetic acid-induced yeast programmed cell death occurs without macroautophagy | Current Pharmaceutical Biotechnology |